Ruiz-Morales JM, Tapia-Salas I, Dorantes-Heredia R, Chablé-Montero F, Ortega-López N, García-Reyna JC, Motola-Kuba D

Idioma: Español
Referencias bibliográficas: 26
Paginas: 195-199
Archivo PDF: 172.52 Kb.

RESUMEN

Antecedentes. El PET/CT es un estudio que hoy en día es muy útil para el diagnóstico, determinación de respuesta a tratamiento y seguimiento de pacientes con padecimientos oncológicos. El objetivo de este trabajo fue presentar una serie de casos donde se descartó la posible recurrencia de enfermedad oncológica sugerida por PET/CT posterior a tratamiento curativo. Material y métodos. Revisamos casos de padecimientos oncológicos tratados en el Hospital Médica Sur de 2005 al 2012 con intento curativo y seguimiento con PET/CT y probable recurrencia. Resultados. Se encontraron cincos casos que cumplieron nuestros criterios de inclusión, cuyas lesiones de probable recurrencia fueron en cuatro de ellos tuberculosis y un caso de reacción inflamatoria. Conclusión. Ante pacientes oncológicos, tratados con intento curativo de su enfermedad, se debe realizar una biopsia de la lesión para excluir posibles patologías de otra naturaleza no oncológica.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, Ravn J, et al. Preoperatives taging of lung cancer with combined PET-CT. N Engl J Med 2009; 361: 32-9.

2. Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, Harris LJ, et al. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinicalpractice guidelines. Chest 2013; 143: e211S-e250S.

3. Lu Y, Xie D, Huang W, Gong H, Yu J. 18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients. Neoplasma 2010; 57: 129-34.

4. Song JW, Oh YM, Shim TS, Kim WS, Ryu JS, Choi CM. Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer. Lung Cancer 2009; 65: 333-8.

5. Ha PK, Hdeib A, Goldenberg D.The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006; 132: 12-6.

6. Das CJ, Kumar R, Balakrishnan VB, Chawla M, Malhotra A. Disseminated tuberculosis masquerading as metastatic breast carcinoma on PET-CT. Clin Nucl Med 2008; 33: 359-61.

7. Kim KS. Primary nasopharyngeal tuberculosis mimicking carcinoma: a potentially false-positive PET/CT finding. Clin Nucl Med 2010; 35: 346-8.

8. Sharma P, Marangmei C. Tubercular Meningitis on 18F-FDG PET/CT: Incidentally Detected and Masquerading as Relapse in a Patient With Ovarian Burkitt Lymphoma. Clin Nucl Med 2015; 40: 606-7.

9. Chen C, Zhu Y-H, Qian H-Y, Huang J-A. Pulmonary tuberculosis with false-positive (18) F-fluorodeoxyglucose positron emission tomography mimicking recurrent lung cancer: A case report. Exp- Ther Med 2015; 9: 159-61.

10. Umeoka S, Koyama T, Saga T, Higashi T, Ito N, Kamoto T, Kotani H, et al. High 18 F-fluoro de oxyglocose up take in adrenal histoplasmosis; a case report. Eur Radiol 2005; 15: 2483-6.

11. Thomas DL, Syrbu S, Graham MM. Epstein-Barr virus mimicking lymphoma on FDG-PET/CT. Clin Nucl Med 2009; 34: 891-3.

12. Ivanova K, Glatz K, Zippelius A, Nicolas G, Itin P. Acute toxoplasmosis mimicking melanoma metastases: review of conditions causing false-positive results on (18) F-FDG PET/CT. Dermatology 2012; 225: 349-53.

13. Gupta NC, Graeber GM, Bishop HA.Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest 2000; 117: 773-8.

14. Cheng N-M, Yeh T-W, Ho K-C. False positive F-18 FDG PET/CT in neck and mediastinum lymph nodes due to anthracosis in a buccal cancer patient. Clin Nucl Med 2011; 36: 963-4.

15. Grove N, Zheng M, Bristow RE, Eskander RN. Extensive Tattoos Mimicking Lymphatic Metastasis on Positron Emission Tomography Scan in a Patient With Cervical Cancer. Obstet Gynecol 2015; 126: 182-5.

16. Lee YK, Seo JB, Kim SS, Lim T-H.Thoracic periaortic fibrosis mimicking malignant tumor: CT and 18F-FDG PET findings. AJR 2007; 188: 345-7.

17. Baum RP, Rösch F. World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy (PRRNT), June 23-26, 2011, Zentralklinik Bad Berka, Germany. World J Nucl Med 2011; 10: 1-2.

18. Lim D, Lee SY, Lim KH, Chan CY. Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan. World J Gastroenterol 2013; 19: 4432-6.

19. Mansberg R, Ho B, Bui C, Crombie C. False Positive F-18 FDG PET/CT of Skel et al Metastasis Due to Solitary Eosinophilic Granuloma. Mol Imaging Radionucl Ther 2013; 22: 103-5.

20. Crucitti A, Grossi U, Leccisotti L. Food residue granuloma mimick ing metastatic disease on FDG-PET/CT. Jpn J Radiol 2013; 31: 349-51.

21. Riad R, Omar W, Sidhom I. False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt’s lymphoma. Nucl Med Commun 2010; 31: 232-8.

22. Urbanellis P, Chin-Lenn L, Teman CJ, McKinnon JG. Kikuchi- Fujimoto lymphadenitis imitating metastatic melanoma on positron emission tomography: a case report. BMC Surg 2015; 15: 50.

23. Pawlik TM, Erasmus JJ, Truong MT, Macapinlac H, Ross MI, Gershenwald JE. Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma. AJR 2006; 187: W117-W119.

24. Ames J, Blodgett T, Meltzer C. 18F-FDG up take in an ovary containing a hemorrhagic corpus luteal cyst: false-positive PET/ CT in a patient with cervical carcinoma. AJR 2005; 185: 1057-9.

25. Long NM, Smith CS. Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging. Insights Imaging 2011; 2: 679-98.

26. Yasar Z, Acat M, Onaran H. False-positive 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET/CT) scans mimicking malignancies. Med Glas (Zenica) 2015; 12: 40-6.